Oscotec Inc. (039200.KQ)
KRW 24450.0
(-2.4%)
KRW 24450.0
(-2.4%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.95 Billion KRW | -2.2% |
| 2022 | 5.06 Billion KRW | 29.71% |
| 2021 | 3.9 Billion KRW | -91.02% |
| 2020 | 43.47 Billion KRW | 895.09% |
| 2019 | 4.36 Billion KRW | -76.64% |
| 2018 | 18.7 Billion KRW | 378.51% |
| 2017 | 3.9 Billion KRW | 9.98% |
| 2016 | 3.55 Billion KRW | -80.62% |
| 2015 | 18.33 Billion KRW | 7.16% |
| 2014 | 17.11 Billion KRW | -21.72% |
| 2013 | 21.85 Billion KRW | -11.7% |
| 2012 | 24.75 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.06 Billion KRW | 247.32% |
| 2024 Q2 | 1.55 Billion KRW | 46.31% |
| 2023 Q1 | 1.14 Billion KRW | -16.38% |
| 2023 Q3 | 1.69 Billion KRW | -5.78% |
| 2023 Q4 | 305.77 Million KRW | -81.97% |
| 2023 FY | 4.95 Billion KRW | -2.2% |
| 2023 Q2 | 1.8 Billion KRW | 56.72% |
| 2022 Q4 | 1.37 Billion KRW | 23.46% |
| 2022 Q3 | 1.11 Billion KRW | -27.98% |
| 2022 Q1 | 1.03 Billion KRW | -11.08% |
| 2022 FY | 5.06 Billion KRW | 29.71% |
| 2022 Q2 | 1.54 Billion KRW | 49.89% |
| 2021 Q2 | 996.27 Million KRW | 11.35% |
| 2021 Q4 | 1.15 Billion KRW | 35.95% |
| 2021 Q1 | 894.71 Million KRW | -96.59% |
| 2021 FY | 3.9 Billion KRW | -91.02% |
| 2021 Q3 | 852.6 Million KRW | -14.42% |
| 2020 Q2 | 15.52 Billion KRW | 1533.48% |
| 2020 Q1 | 950.48 Million KRW | 3.02% |
| 2020 Q4 | 26.21 Billion KRW | 3247.25% |
| 2020 FY | 43.47 Billion KRW | 895.09% |
| 2020 Q3 | 783.06 Million KRW | -94.96% |
| 2019 Q2 | 1.11 Billion KRW | 1.35% |
| 2019 FY | 4.36 Billion KRW | -76.64% |
| 2019 Q4 | 922.6 Million KRW | -25.31% |
| 2019 Q3 | 1.23 Billion KRW | 11.0% |
| 2019 Q1 | 1.09 Billion KRW | -92.89% |
| 2018 Q1 | 1.14 Billion KRW | 75.04% |
| 2018 Q3 | 1.13 Billion KRW | 14.64% |
| 2018 FY | 18.7 Billion KRW | 378.51% |
| 2018 Q4 | 15.43 Billion KRW | 1263.63% |
| 2018 Q2 | 987.63 Million KRW | -13.63% |
| 2017 FY | 3.9 Billion KRW | 9.98% |
| 2017 Q3 | 1.02 Billion KRW | 13.83% |
| 2017 Q4 | 653.28 Million KRW | -36.23% |
| 2017 Q2 | 899.95 Million KRW | -32.38% |
| 2017 Q1 | 1.33 Billion KRW | -1.02% |
| 2016 Q3 | 767.47 Million KRW | 46.04% |
| 2016 Q1 | 916.35 Million KRW | -80.11% |
| 2016 Q2 | 525.52 Million KRW | -42.65% |
| 2016 FY | 3.55 Billion KRW | -80.62% |
| 2016 Q4 | 1.34 Billion KRW | 75.19% |
| 2015 Q3 | 5.66 Billion KRW | 52.82% |
| 2015 Q4 | 4.6 Billion KRW | -18.67% |
| 2015 Q2 | 3.7 Billion KRW | -14.93% |
| 2015 Q1 | 4.35 Billion KRW | 17.37% |
| 2015 FY | 18.33 Billion KRW | 7.16% |
| 2014 Q1 | 4.72 Billion KRW | 31.76% |
| 2014 FY | 17.11 Billion KRW | -21.72% |
| 2014 Q4 | 3.71 Billion KRW | -21.64% |
| 2014 Q3 | 4.73 Billion KRW | 20.32% |
| 2014 Q2 | 3.93 Billion KRW | -16.62% |
| 2013 Q2 | 6.14 Billion KRW | 0.48% |
| 2013 Q3 | 6.01 Billion KRW | -2.05% |
| 2013 Q1 | 6.11 Billion KRW | 30.96% |
| 2013 Q4 | 3.58 Billion KRW | -40.44% |
| 2013 FY | 21.85 Billion KRW | -11.7% |
| 2012 Q4 | 4.66 Billion KRW | -40.96% |
| 2012 FY | 24.75 Billion KRW | 0.0% |
| 2012 Q3 | 7.9 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| BCWORLD PHARM. Co., Ltd. | 75.11 Billion KRW | 93.408% |